Strontium Citrate

Strontium is a naturally occurring element that sits just below calcium in the periodic table and behaves chemically much like it, so the body takes it up and deposits it into bone in place of some calcium. Strontium citrate is the strontium salt of citric acid, a form that dissolves readily and is sold as a nutritional supplement, typically for people concerned about bone density or osteoporosis. It is available without a prescription in many countries as capsules or tablets.

A crucial distinction separates strontium citrate from strontium ranelate. Strontium ranelate is a patented pharmaceutical that was studied in large randomized trials in postmenopausal women, where it reduced the risk of spinal and other fractures by roughly a third to forty percent ^[2][3]. Those results, however, were obtained with the specific ranelate formulation, and network analyses of osteoporosis treatments have included ranelate rather than the citrate supplement ^[4]. The over-the-counter citrate form has not been subjected to the same rigorous fracture trials, and its benefits are largely inferred rather than directly proven. An animal comparison of different strontium salts even found that the citrate form produced the weakest effect on bone mineral density among the forms tested ^[1].

One technical point often raised is that strontium interferes with the standard test used to measure bone density. Because a strontium atom is much heavier than a calcium atom, its presence in bone artificially inflates the readings from dual-energy x-ray absorptiometry, the common DXA scan. As a result, apparent gains in bone density in people taking strontium can overstate the true increase in bone strength, which complicates interpretation of any measured improvement.

The regulatory histories of the two forms differ sharply. Strontium ranelate was approved in Europe for severe osteoporosis but was later restricted and largely withdrawn after data linked it to an increased risk of heart attack and blood clots, and it was never approved in the United States ^[2]. Strontium citrate, by contrast, is marketed as a dietary supplement rather than an approved medicine, so it is not held to the same evidence standard, and whether the cardiovascular concerns raised for ranelate apply to it is not established. People considering it are generally advised to discuss it with a clinician, particularly given the DXA measurement issue and the limited direct evidence.

Strontium ranelate carried warnings for blood clots and cardiovascular events, so caution is reasonable. It can interfere with calcium absorption and skews bone density scans. Take it separately from calcium and avoid if you have clot risk.

Strontium is a divalent cation and behaves like one, so its interactions are absorption interactions rather than metabolic ones. Tetracyclines and fluoroquinolones chelate with strontium in the gut and lose bioavailability, the same problem calcium, magnesium and iron cause with those antibiotics; separation in time is what preserves both drugs.

Calcium is the mirror image. Calcium and strontium compete for the same intestinal absorption pathway, so calcium supplements, dairy and food in general reduce how much strontium is taken up, and strontium in turn reduces calcium uptake. Aluminum and magnesium antacids blunt strontium absorption as well.

One further point is not a drug interaction but is regularly mistaken for one. Strontium has a higher atomic number than calcium and attenuates X-rays more strongly, so once it is incorporated into bone it inflates DXA bone mineral density readings. An unadjusted scan overstates the real gain in bone, sometimes substantially, which makes apparent responses hard to interpret.

Checking a whole stack? Run it through interactions + stacks.